Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - DepoMed, Inc. (AMEX:DMI)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Research | SEC | Msgs | Insider | Financials
Recent Events
Aug 28Price hit new 52-week high ($7.05)
Aug 14Earnings Announcement
Location
1360 O'Brien Drive
Menlo Park, CA 94025
Phone: (650) 462-5900
Fax: (650) 513-0999
Employees (last reported count): 27
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Biotechnology & Drugs
Company Websites
 ·Home Page
 ·Yahoo! Category

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 63%
·Institutional: 66% (177% of float)
(15 institutions)
·Net Inst. Buying: 3.20M shares (+29.59%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
DepoMed, Inc. is a development-stage company engaged in the development of new and proprietary oral drug delivery technologies. The Company has developed two types of oral drug delivery systems, the Gastric Retention System (the GR System) and the Reduced Irritation System (the RI System). The GR System is designed to be retained in the stomach for an extended period of time while it delivers the incorporated drug or drugs, and the RI System is designed to reduce the gastrointestinal irritation that is a side effect of many orally administered drugs. In addition, the DepoMed Systems are designed to provide continuous, controlled delivery of an incorporated drug.
More from Market Guide: Expanded Business Description

Financial Summary
DepoMed, Inc. is a development stage company engaged in the development of new and proprietary oral drug delivery technologies designed to reduce gastrointestinal irritation and provide continuous, controlled delivery of an incorporated drug. For the six months ended 6/30/01, revenues rose 53% to $1.5 million. Net loss applicable to Common totaled $8.6 million, up from $4.2 million. Results reflect new collaborative agreements, offset by higher clinical trial costs.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY2000 Pay

John Fara, Ph.D., 58
Chairman, Pres, CEO
$451K
John Hamilton, 56
VP- Fin., CFO
226K
John Shell, 47
VP - Operations, Director
205K
Bret Berner, Ph.D., 48
VP- Product Devel.
205K
Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc..
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- AMEX:DMIAs of 31-Aug-2001
Price and Volume
52-Week Low
on 2-Oct-2000
$2.25 
Recent Price$6.70 
52-Week High
on 28-Aug-2001
$7.05 
Beta0.47 
Daily Volume (3-month avg)30.1K
Daily Volume (10-day avg)38.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y]
52-Week Change+118.7%
52-Week Change
relative to S&P500
+193.5%
Share-Related Items
Market Capitalization$77.2M
Shares Outstanding11.5M
Float4.30M
Dividends & Splits
Annual Dividendnone 
Last Splitnone 
Per-Share Data
Book Value (mrq)-$0.46 
Earnings (ttm)-$1.79 
Earnings (mrq)-$0.56 
Sales (ttm)$0.28 
Cash (mrq)$0.97 
Valuation Ratios
Price/BookN/A 
Price/EarningsN/A 
Price/Sales (ttm)24.06 
Income Statements
Sales (ttm)$2.29M
EBITDA (ttm)-$10.8M
Income available to common (ttm)-$14.9M
Profitability
Profit MarginN/A 
Operating MarginN/A 
Fiscal Year
Fiscal Year EndsDec 31
Most recent quarter30-June-2001
Management Effectiveness
Return on Assets (ttm)-159.26%
Return on EquityN/A 
Financial Strength
Current Ratio (mrq)3.89 
Debt/Equity (mrq)0.47 
Total Cash (mrq)$11.2M
Short Interest
As of 8-Aug-2001
Shares Short63.0K
Percent of Float1.5%
Shares Short
(Prior Month)
63.0K
Short Ratio2.33 
Daily Volume27.0K
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Some event data provided by CCBN. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.